
Less Food
Effective GLP-1 therapy can substantially reduce appetite and food intake. That is part of why the therapy works. But less total food also means fewer opportunities to obtain everything the body still needs.
Clinically studied. Recommended by 2,000+ verified clinicians. 15M+ NOVOS servings enjoyed worldwide. 81% of NOVOS customers feel a difference within 2 weeks
GLP-1 + Healthy Weight Loss
GLP-1-based therapies can make eating less dramatically easier. But muscle, protein, micronutrients, skin, strength and long-term health still need attention.
NOVOS helps support the quality of your GLP-1 journey.
Educational content for people using or considering clinician-prescribed GLP-1-based weight-management therapy. NOVOS products are foods and dietary supplements, not medications, and are not intended to increase the effectiveness of GLP-1 therapy.

A transformation measured in more than pounds.
The Second Half of the Journey
GLP-1s can make eating less easier. They do not automatically solve the nutrition, muscle, skin, fitness or longevity questions that follow.
The goal is not simply less weight.
It is better body composition and better health.
Quality of Weight Loss
Body weight is the sum of several compartments. Two people can lose the same number of pounds with very different effects on health and function.
Simulated scale
200
POUNDS
The target of healthy weight loss.
Includes skeletal muscle, other non-fat tissues and body water.
Fluctuates with diet, glycogen and hydration.
Largely stable in healthy adults.
Weight loss can come from several compartments.
Lose excess fat.
Preserve as much muscle, strength and function as practical.
Conceptual illustration. Not individual clinical data.
Lean mass is not synonymous with skeletal muscle. It includes multiple non-fat tissues and body water: organs, connective tissue, bone and the water held within them, alongside muscle.
When a study reports lean-mass change during weight loss, only part of that change reflects skeletal muscle. This is why sensational claims like a fixed percentage of weight lost being muscle are misleading.
25%
to 39%
In a 2026 meta-analysis of randomized incretin trials, lean mass represented roughly 25% to 39% of total weight lost depending on therapy.
IMPORTANT
Lean mass is not the same as skeletal muscle.
Resistance-training lifestyle interventions in the analysis showed a more favorable lean-mass profile.
Muscle preservation during weight loss is a system, not a pill. Exercise remains foundational.

1
Resistance training
The signal.

2
Adequate protein
The building material.

3
Nutrition + recovery
The environment.

PRIMARY
NOVOS Bar
Primary nutritional layer.

NOVOS Core
Supporting recovery and muscle-function systems.

NOVOS Boost
Optional cellular-energy layer.
No NOVOS product has been shown to prevent lean-mass loss during GLP-1 therapy. Resistance training, adequate total protein and individualized medical guidance remain the relevant strategy.
Make It Personal
Choose a goal to see why it matters and where NOVOS fits, honestly.

Why it matters
Protein supports muscle-building nutrition during weight loss.
Best NOVOS fit
NOVOS Bar
Important limit
One Bar does not represent an individual's entire daily protein requirement.
The NOVOS GLP-1 System
Not every product is equally relevant to this journey. Bar leads. Core, Vital and Boost play defined supporting roles.

Nutrition when every bite counts.
ESTABLISHED NUTRITION + INGREDIENT RESEARCH
Bar is the most directly relevant NOVOS product during active GLP-1 weight loss because it helps make a smaller eating occasion more nutritionally useful.
The Primary GLP-1 Nutrition Product
The GLP-1 challenge Bar addresses is not medication efficacy. It is nutrition. When someone is eating substantially less, a compact source of complete protein, fiber and micronutrients can become especially useful.
15 g
Complete protein
6 to 7 g
Fiber
21
Essential vitamins + minerals
50%
Daily Value of those nutrients
Nutrition values reflect the current NOVOS Bar formulation. See the product page for the live nutrition panel.


Resistance training provides the adaptation signal. Protein supplies amino acids used to rebuild muscle tissue. NOVOS Bar provides complete plant protein containing all nine essential amino acids.
Bar supports the nutrition.
Training provides the signal.
Major weight loss can include both fat and lean tissue. Protein supplies the amino acids muscle uses for maintenance and remodeling, while resistance training provides the adaptive stimulus that tells the body to keep that tissue.
When total food intake drops substantially, reaching adequate protein from ordinary meals can become harder. Compact, protein-dense foods can help close the gap as part of an overall diet.
One Bar contributes protein toward, but does not cover, an entire daily requirement. Individual needs vary with body size, age and activity; speak with the clinician managing your medication or a registered dietitian for personal targets.

Eating less means fewer opportunities to obtain vitamins and minerals from food. NOVOS Bar was designed to make one eating occasion more nutritionally complete, with 21 essential vitamins and minerals at 50% Daily Value.
Fewer bites. More nutrition per bite.
No. Deficiency is not inevitable, and actual nutritional requirements and food intake vary widely. The concern is nutritional adequacy when overall intake becomes very low for an extended period.
NOVOS Bar is a nutrient-dense food option, not a treatment for any diagnosed deficiency. If you suspect a deficiency, ask your clinician about appropriate testing and care.
NOVOS Bar contributes meaningful dietary fiber. But GI tolerance can vary substantially during GLP-1 therapy. Someone experiencing marked nausea, bloating, vomiting or severe early fullness should not force a high-fiber eating occasion simply to meet a target.
Nutrition has to work with your stomach.
NOVOS Bar is not a treatment for constipation. Bowel habits during GLP-1 therapy are influenced by hydration, overall food pattern, the medication itself and individual tolerance.
Practical basics include fluids, movement and gradually adjusting fiber to comfort. Persistent or significant symptoms should be discussed with the clinician managing your medication.
NOVOS Bar combines complete protein, fiber and micronutrients with real-food ingredients: organic olive oil, seed butters, honey, vegetables, cranberry and cocoa.
Functional ingredients are the bonus. Nutrition is the foundation.
Built into every Bar. Value-adds on top of the nutrition, not the reason Bar matters here.

Flexibility, Not Rules
15 g
protein
6 to 7 g
fiber
21
vitamins + minerals
A nutrient-dense snack or smaller eating occasion when appetite is limited.
Do not force a predetermined portion.
Appetite and GI tolerance vary substantially. The amount someone eats should fit their individual needs, tolerance and healthcare guidance.
Visible Changes
Substantial weight loss can reduce facial fat volume and increase visible laxity. The popular phrase "Ozempic face" is not a diagnosis.
A supplement cannot replace lost facial volume.
No NOVOS product has been shown to prevent or restore lost facial fat volume.


Primary skin support
Preliminary finished-formula skin-firmness research: 22% average improvement, n=4, 6-month pilot.
Preliminary. This does not demonstrate prevention or treatment of GLP-1-related skin laxity or facial volume loss.

Nutritional foundation
Nutrition supports the raw materials skin relies on.
Bar does not prevent loose skin.

Environmental / carotenoid support
Daily-system support under the current Vital formulation and brand guidelines.
Vital does not prevent facial fat loss.
The Healthspan Layer
GLP-1 therapy can be a powerful health inflection point. Core's role is not to increase weight loss. Its role is to help broaden the goal from less weight to better healthspan.

GLP-1-based therapies themselves can provide meaningful cardiometabolic benefits in appropriate populations. Core is not a correction for anything the medication fails to do.
In separate research unrelated to GLP-1 treatment, the complete NOVOS Core formulation has been studied in randomized, double-blind, placebo-controlled human research.
SEPARATE NOVOS CORE HUMAN RESEARCH
This trial was not conducted in GLP-1 users and did not study weight loss or obesity treatment.

The scale can be the catalyst.
It should not be the finish line.

Targeted Daily System Support
Vital is a Daily System Support gummy: daily support against oxidative and environmental stress, with targeted support for your eyes, skin, gut and brain.
Chicory Root Inulin
4 g chicory root for prebiotic support.
At the relevant serving structure, chicory-root inulin feeds bifidobacteria, the beneficial bacterial population shown to respond to inulin.
Prebiotic support is not GLP-1 side-effect treatment.
Vital is not intended to treat constipation, nausea, delayed gastric emptying, bloating or other medication adverse effects, and it does not increase weight loss.
Weight loss isn't the only thing happening in your life.
Vital's broader role is daily support for systems exposed to everyday stress.
Lutein + zeaxanthin support the eye's protective pigment, with ingredient research on eye strain and fatigue.
Carotenoid support for skin exposed to everyday oxidative and environmental stress.
Ingredient research on memory and learning under the current Vital formulation guidelines.
These are general daily-system benefits, not consequences of GLP-1 treatment.


Nausea, early satiety, constipation, diarrhea, vomiting and bloating can all change what and how much someone comfortably eats during GLP-1 therapy.
NOVOS products are not treatments for these side effects.
Prioritize small, nutrient-dense, easy-to-tolerate foods and fluids. Cold or neutral foods are often easier than large hot meals. Eat to comfort, not to a fixed quota.
Increase fiber gradually and only to tolerance. During periods of marked nausea or bloating, it is reasonable to favor gentler foods rather than forcing fiber targets.
Persistent vomiting, inability to hydrate, severe or persistent abdominal pain, or inability to maintain adequate nutrition warrants prompt medical guidance. Speak with the clinician managing your medication before making any medication changes.
The Journey
Priorities shift as therapy progresses. Select a phase to see what matters most and where NOVOS fits.
Priorities
Where NOVOS fits
An honest matrix of where each product is strong, and where it is not.
What matters most?

BEST FIT
NOVOS Bar
15 g complete plant protein in a compact eating occasion.
Important limit: One Bar is not a full day's protein target.
Explore NOVOS Bar"The taste is genuinely good and it holds me over. It has become my go-to when I do not feel like a full meal."
Karen M.Verified Customer · NOVOS Bar"Convenient, real ingredients, and it does not taste like a protein bar. I keep them in my bag and in the office."
David R.Verified Customer · NOVOS Bar"Simple to take every morning and I appreciate that the formula is backed by actual published work."
Susan L.Verified Customer · NOVOS CoreIndividual experiences vary and are not clinical evidence.

Professor of Genetics, Harvard Medical School

Research Professor, Salk Institute for Biological Studies

Director of Research, NOVOS
Titles and affiliations reflect the NOVOS Scientists page. Advisory involvement does not constitute an endorsement of any GLP-1-related claim.

Most people actively losing weight
Protein, fiber, micronutrient density and real-food nutrition when eating opportunities are smaller.
Explore NOVOS Bar
Ready to turn weight loss into a longevity project
Broader healthy-aging support with human cardiovascular research and additional skin and recovery ingredients.
Explore NOVOS Core
Gut + daily system support is a priority
Targeted chicory-root prebiotic support plus eye, skin and brain daily-system support.
Explore NOVOS Vital
Focused NAD+ is already a personal priority
Focused NMN and NAD+ support.
Explore NOVOS BoostNot sure?
Answer a few questions and get a recommendation based on your goals and where you are in the journey.
Product FinderNOVOS Bar is the most directly relevant product for many people actively losing weight because it provides complete protein, fiber, broad micronutrient nutrition and real-food ingredients in a compact eating occasion. It does not make the medication work better or cause additional weight loss.
No. Bar provides complete protein, which can help support adequate protein intake. Resistance training, adequate total protein, sufficient nutrition and individualized medical guidance remain the relevant muscle-preservation strategy. The finished Bar has not been clinically shown to prevent GLP-1-related lean-mass loss.
Major weight loss can include both fat and lean tissue. Protein supplies amino acids used by muscle, while resistance training provides the adaptive stimulus.
No. Nutritional requirements and actual food intake vary. The concern is that substantial appetite reduction can reduce opportunities to obtain protein and micronutrients. NOVOS Bar is a nutrient-dense food option, not treatment for deficiency.
Vital provides chicory-root inulin for targeted prebiotic support under the current Vital formulation and brand guidelines. It is not intended to treat constipation, nausea, delayed gastric emptying or other medication adverse effects.
Substantial weight loss can reduce facial fat volume and increase visible laxity. No NOVOS product has been shown to prevent or restore lost facial fat volume. Core, Bar and Vital can support different aspects of skin quality and nutrition, but this is different from restoring facial volume.
Core is relevant to the broader health goal rather than medication efficacy. The complete formula has separate randomized human research involving cardiovascular-aging physiology, and Core is designed as the broader NOVOS longevity foundation. The study was not performed in GLP-1 users.
Not established. Boost supplies NMN for focused NAD+ support. It has not been shown to increase GLP-1-driven weight loss.
Do not force food or supplements simply to follow a generic nutrition plan. Persistent vomiting, inability to maintain hydration, severe or persistent abdominal pain, or inability to maintain adequate nutrition should be discussed promptly with the clinician managing the medication.
No NOVOS product has been shown to prevent weight regain after stopping GLP-1 therapy. Long-term management can involve nutrition, resistance training, physical activity, sleep, sustainable habits and continued medical care. Medication decisions belong with the prescribing clinician.
The weight is coming off.
Keep the muscle.
Keep the nutrition.
Build the strength.
Support the rest of your health.
Take the win.
Build on it.
Start with Nutrition
